Science Supporting Ephedra Ban Fails FDA’s Own Standard – Nutraceutical

Scientific evidence used by FDA to support its outright ban of ephedra would not meet the agency's "own criteria for competent scientific evidence," low-dose ephedra marketer Nutraceutical asserts

More from Archive

More from Pink Sheet